3004 ORAL Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) in the first-line treatment of metastastic colorectal cancer (mCRC): a large-scale phase II study, OPUS

作者: C. Bokemeyer , E. Staroslawska , A. Makhson , I. Bondarenko , J.T. Hartmann

DOI: 10.1016/S1359-6349(07)70932-1

关键词:

摘要:

参考文章(0)